SEShaimaa Ahmed ElShebiney

Shaimaa Ahmed ElShebiney

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shaimaa Ahmed ElShebiney has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Mostafa Mabrouk

    Refractories, Ceramics and Building Materials Department, National Research Centre, 33 El Bohouth St. (Former EL Tahrir St.), Dokki, Giza 12622, Egypt

    5 shared publications
  • Hanan H. Beherei

    Refractories, Ceramics and Building Materials Dept, National Research Centre (NRC), Giza, Egypt

    3 shared publications
  • Neveen A. Salem

    Narcotics, Ergogenics and Poisons Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt

    3 shared publications
  • Sayed H. Kenawy

    Refractories, Ceramics and Building Materials Department, National Research Centre, Dokki, Giza, Egypt

    3 shared publications
  • Gehan T. El-Bassyouni

    Refractories, Ceramics and Building Materials Department, National Research Centre, Dokki, Giza, Egypt

    2 shared publications
  • Omar Mohamed E. Abdel Salam

    Department of Toxicology and Narcotics, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Cairo, Egypt

    2 shared publications

Latest Publications

  • Open Access

    Modulation of experimental Alzheimer’s disease in rats through donepezil-loaded CSF implant

    by Lamyaa Osama, Shaimaa ElShebiney, Hanan H. Beherei, Emad M. Elzayat, Mostafa Mabrouk

    Alzheimer’s disease (AD) is a growing challenge worldwide, with current treatments largely symptomatic and limited. The current study aimed to introduce coated nanoporous membranes for localized drug delivery of donepezil, combining both antifouling activity and sustained drug release, unlike traditional Alzheimer’s treatments that rely on systemic administration. Nanoporous membranes were prepared by electrochemical anodization, coated with Polymethyl methacrylate (PMMA) or a PMMA/polyurethane (PU) mixture to mitigate biofouling. The fabricated nanoporous membranes before and after coating were characterized using SEM/EDX, FTIR, BET, and contact angle measurements. In vitro drug release and release kinetics were studied in artificial cerebrospinal fluid (ACSF). Coated and donepezil loaded membranes were implanted on the dura surface in Wistar rats AD model via intracerebral streptozotocin (STZ) injection. The activity was evaluated on behavioral, biochemical and histological levels. PMMA enhanced membrane hydrophobicity (contact angle increased from 62.8° to 79°) and sustained drug release over 7 days, making it the preferred coating. The PMMA membrane demonstrated a reduction in beta-amyloid levels without being loaded with donepezil, while the donepezil-loaded membrane showed cognitive function improvement in Morris water maze and Y-maze. Acetylcholinesterase activity was elevated after STZ-induction of AD and got ameliorated by the membranes implantation. Brain-Derived Neurotrophic Factor (BDNF) was lowered by STZ, while increased in treated animals. Histological examination revealed the neuronal regeneration after donepezil-loaded PMMA coated membrane. These findings suggest that coated nanoporous membranes are promising systems for localized active donepezil drug delivery for AD-like symptoms modulation in STZ-induced AD model, warranting further validation in other AD paradigms.


  • A novel tramadol–polycaprolactone implant could palliate heroin conditioned place preference and withdrawal in rats: behavioral and neurochemical study

    by Shaimaa A. Elshebiney, Rania A. Elgohary, Marwa E. El-Shamarka, Mostafa Mabrouk, Hanan H. Beheri

    Drug dependence is a chronic brain disease characterized by craving and recurrent episodes of relapse. Tramadol HCl is a promising agent for withdrawal symptoms management, considering its relatively low abuse potential and safety. Oral administration, however, is not preferred in abstinence maintenance programs. Introducing an implantable, long-lasting formula is suggested to help outpatient abstinence programs achieve higher rates of treatment continuation. Tramadol implants (T350 and T650) were prepared on polycaprolactone polymer ribbons by the wet method. Male Wistar rats were adapted to heroin-conditioned place preference (CPP) at escalating doses (3–30 mg/kg, intraperitoneally, for 14 days). Implants were surgically implanted in the back skin of rats. After 14 days, the CPP score was recorded. Naloxone (1 mg/kg, intraperitoneally) was used to induce withdrawal on day 15, and symptoms were scored. Elevated plus maze and open field tests were performed for anxiety-related symptoms. Striata were analyzed for neurochemical changes reflected in dopamine, 3,4-dihydroxyphenyl acetic acid, gamma-aminobutyric acid, and serotonin levels. Brain oxidative changes including glutathione and lipid peroxides were assessed. The tramadol implants (T350 and T650) reduced heroin CPP and limited naloxone-induced withdrawal symptoms. The striata showed increased levels of 3,4-dihydroxyphenyl acetic acid, and serotonin and decreased levels of gamma-aminobutyric acid and dopamine after heroin withdrawal induction, which were reversed after implanting T350 and T650. Implants restore the brain oxidative state. Nonsignificant low naloxone-induced withdrawal score after the implant was used in naive subjects indicating low abuse potential of the implants. The presented tramadol implants were effective at diminishing heroin CPP and withdrawal in rats, suggesting further investigations for application in the management of opioid withdrawal.


  • Open Access

    Copper‐doped magnesium phosphate nanopowders for critical size calvarial bone defect intervention

    by Sara A. M. El‐Sayed, Shaimaa ElShebiney, Hanan H. Beherei, Pradeep Kumar, Yahya E. Choonara, Mostafa Mabrouk

    Calvarial defects of bone present difficult clinical situations, and their restoration using biocompatible materials requires special treatments that enable bone regeneration. Magnesium phosphate (MgP) is known as an osteoinductive biomaterial because it contains Mg2+ ions and P ions that enhance the activity of osteoplast cells and help in bone regeneration. In this study, MgP and CuO‐doped MgP were fabricated and characterized for their physicomechanical properties, particle size, morphology, surface area, antibacterial test, and in vitro bioactivity evaluation using the following techniques: X‐rays diffraction, Fourier‐transformer infrared, TEM, and Brunauer, Emmett and Teller (BET) surface area, X‐rays photoelectron spectroscopy (XPS), and Scanning electron microscopy (SEM). Furthermore, these nanopowders were implanted in adult inbred male Wistar rats and studied after two periods (28 and 56 days). The results demonstrated that the obtained semiamorphous powders are in nanoscale (≤ 50 nm). XPS analysis ensured the preparation of MgP as mono MgP and CuO were incorporated in the structure as Cu2+. The bioactivity was supported by the observation of calcium phosphate layer on the nanopowders' surface. The in vivo study demonstrated success of MgP nanopowders especially those doped with CuO in restoration of calvarial defect bone. Therefore, fabricated biomaterials are of great potential in restoration of bone calvarial defects.


  • Open Access

    Post-coronavirus disease 2019 frequent use of disinfectants and sanitizers affect lung tissue: experimental study

    by Amr Khattab, Shaimaa ElShebiney

    Background/aim: Regular and excessive use of general household disinfectants and hand sanitizers has increased since coronavirus disease 2019 (COVID-19) hit as per World Health Organization (WHO) recommendations. However, existing knowledge about hypochlorite use as a disinfectant is inadequate for the applied experimental conditions are generally not translated to real life. This study explores the effect of the regular use of the commonly recommended disinfectants such as alcohol-based solutions and 0.1% hypochlorite on the lung and liver tissues of rats. Materials and methods: Sixteen Wistar rats were assigned to two housing conditions, first group cages were cleaned regularly with tap water. The second group was exposed to regular sanitization of the cages twice daily for 2 months using 70% alcohol followed by 1% hypochlorite solution, 30 min apart. Serum redox state was evaluated and serum liver enzymes were assessed. Lung and liver tissues were examined biochemically for inflammatory markers such as IL-1B, NF-kB, VEGF, and oxidant biomarkers such as MDA and antioxidant markers including GSH, SOD, and GPx. A histological examination was performed. Results: Serum liver enzymes, antioxidants in serum or liver tissues and the inflammatory biomarkers in liver tissue were insignificantly changed, while lung tissue was inflamed and proceeded to fibrotic changes and the inflammatory biomarkers of IL-1β and NF-kβ, and VEGF of lung tissue were significantly elevated (P < 0.05) after surface disinfectant exposure to alcohol followed by 0.1% hypochlorite solution for two months. Moreover, the GSH and GPx levels were significantly reduced (P < 0.05), while the MDA level was significantly increased (P < 0.05) in the serum and lungs of a disinfectant exposed group of rats. Conclusion: Frequent and excessive exposure to alcohol followed by 0.1% hypochlorite solution even as recommended can pose a risk to the respiratory system. Their application in cleaning routine should be wisely considered.

  • Open Access

    Natural Polyphenols—Resveratrol, Quercetin, Magnolol, and β-Catechin—Block Certain Aspects of Heroin Addiction and Modulate Striatal IL-6 and TNF-α

    by Shaimaa ElShebiney, Rania Elgohary, Marwa El-Shamarka, Noha Mowaad, Osama A. Abulseoud

    We have examined the effects of four different polyphenols in attenuating heroin addiction using a conditioned place preference (CPP) paradigm. Adult male Sprague Dawley rats received heroin (alternating with saline) in escalating doses starting from 10 mg/kg, i.p. up to 80 mg/kg/d for 14 consecutive days. The rats were treated with distilled water (1 mL), quercetin (50 mg/kg/d), β-catechin (100 mg/kg/d), resveratrol (30 mg/kg/d), or magnolol (50 mg/kg/d) through oral gavage for 7 consecutive days, 30 min before heroin administration, starting on day 8. Heroin withdrawal manifestations were assessed 24 h post last heroin administration following the administration of naloxone (1 mg/kg i.p). Heroin CPP reinstatement was tested following a single dose of heroin (10 mg/kg i.p.) administration. Striatal interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) were quantified (ELISA) after naloxone-precipitated heroin withdrawal. Compared to the vehicle, the heroin-administered rats spent significantly more time in the heroin-paired chamber (p < 0.0001). Concomitant administration of resveratrol and quercetin prevented the acquisition of heroin CPP, while resveratrol, quercetin, and magnolol blocked heroin-triggered reinstatement. Magnolol, quercetin, and β-catechin blocked naloxone-precipitated heroin withdrawal and increased striatal IL-6 concentration (p < 0.01). Resveratrol administration was associated with significantly higher withdrawal scores compared to those of the control animals (p < 0.0001). The results of this study show that different polyphenols target specific behavioral domains of heroin addiction in a CPP model and modulate the increase in striatal inflammatory cytokines TNF-α and IL-6 observed during naloxone-precipitated heroin withdrawal. Further research is needed to study the clinical utility of polyphenols and to investigate the intriguing finding that resveratrol enhances, rather than attenuates naloxone-precipitated heroin withdrawal.


  • Open Access

    Zinc oxide calcium silicate composite attenuates acute tramadol toxicity in mice

    by Shaimaa A. ElShebiney, Rania Elgohary, Sayed H. Kenawy, Gehan T. El-Bassyouni, Esmat M. A. Hamzawy

    Background: Seizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the drug-induced seizure cases. Although, diazepam clears these seizures, the risk of central respiratory depression cannot be overlooked. Henceforth, three adsorbing composites were examined in a tramadol acute intoxication mouse model. Methods: Calcium Silicate (Wollastonite) either non-doped or wet doped with iron oxide (3%Fe2O3) or zinc oxide (30% ZnO) were prepared. The composites’ adsorption capacity for tramadol was determined in vitro. Tramadol intoxication was induced in Swiss albino mice by a parenteral dose of 120 mg/kg. Proposed treatments were administered within 1 min at 5 increasing doses, i.p. The next 30 min, seizures were monitored as an intoxication symptom. Plasma tramadol concentration was recorded after two hours of administration. Results: The 3% Fe2O3-containing composite (CSFe3), was found to be composed of mainly wollastonite with very little alpha–hematite. On the other hand, hardystonite and wellimite were developed in the 30%ZnO-containing composite (CSZn3). Micro-round and irregular nano-sized microstructures were established (The particle size of CS was 56 nm, CSFe3 was 49 nm, and CSZn3 was 42 nm). The CSZn3 adsorption capacity reached 1497 mg of tramadol for each gram. Tramadol concentration was reduced in plasma and seizures were inhibited after its administration to mice at three doses. Conclusion: The calcium silicate composite doped with ZnO presented a good resolution of tramadol-induced seizures accompanied by detoxification of blood, indicating its potential for application in such cases. Further studies are required.


  • Open Access

    Zinc Oxide Calcium Silicate Composite Attenuates Acute Tramadol Toxicity in Mice

    by Shaimaa A. ElShebiney, Rania Elgohary, Sayed H. Kenawy, Gehan T. El-Bassyouni, Esmat M.A. Hemzawy

    Background Seizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the drug-induced seizure cases. Although, diazepam clears these seizures, the risk of central respiratory depression cannot be overlooked. Henceforth, three adsorbing composites were examined in a tramadol acute intoxication mouse model. Methods Calcium Silicate (Wollastonite) either non-doped or wet doped with iron oxide (3%Fe2O3) or zinc oxide (30% ZnO) were prepared. The composites’ adsorption capacity for tramadol was determined in vitro. Tramadol intoxication was induced in Swiss albino mice by a parenteral dose of 120 mg/kg. Proposed treatments were administered within 1 min at 5 increasing doses, i.p. The next 30 minutes, seizures were monitored as an intoxication symptom. Plasma tramadol concentration was recorded after two hours of administration. Results The 3% Fe2O3-containing composite (CSFe3), was found to be composed of mainly wollastonite with very little alpha–hematite. On the other hand, hardystonite and wellimite were developed in the 30%ZnO-containing composite (CSZn3). Micro-round and irregular nano-sized microstructures were established (The particle size of CS was 56nm, CSFe3 was 49 nm, and CSZn3 was 42 nm). The CSZn3 adsorption capacity reached 1497 mg of tramadol for each gram. Tramadol concentration was reduced in plasma and seizures were inhibited after its administration to mice at three doses. Conclusion The calcium silicate composite doped with ZnO presented a good resolution of tramadol-induced seizures accompanied by detoxification of blood, indicating its potential for application in such cases. Further studies are required.

  • NEUROCHEMICAL AND HISTOLOGICAL BRAIN ALTERATIONS AFTER TRAMADOL ADMINISTRATION TO ROTENONE- INDUCED PARKINSON'S DISEASE IN RATS

    by Shaimaa Elshebiney, Dalia Abuelfadl, Omar Abdel-Salam

    Objective: Tramadol is favorably used for relief of moderate and severe pain. Over 30% of Parkinson’s disease (PD) patients experience persistent pain that has a negative impact on their quality of life. However, its physiological effect in such disorder has not been studied. The current study aimed at investigating the neurochemical and histopathological changes resulting from tramadol administration to experimental PD- induced by rotenone in rats. Methodology: Forty adult male Sprague-Dawley rats were allocated into 5 equal groups; Group 1(control) received saline p.o and DMSO, s.c., Group 2(Rotenone) received rotenone (1.5 mg/kg, s.c., every other day for 12 days), Group 3 (Tramadol) received tramadol HCl given p.o., daily at doses of 20 mg/kg, Group 4 (Rot-Trama 10) PD-induced with rotenone and treated with tramadol HCl, 10 mg/kg, p.o., daily, Group 5(Rot-Trama 20) PD-induced with rotenone and treated with tramadol HCl, 20 mg/kg, p.o., daily. Results : PD-induced rats exhibited significantly reduced dopamine (DA) content (- 33.0%), increased serotonin ( 5-HT) content (+ 11.5%), but no change in 5-hydroxyindole acetic acid (5-HIAA) compared to vehicle-treated counterparts. Rotenone also inhibited both brain paraoxonase 1 (PON1) and acetylcholinesterase (AChE) activities and increased brain oxidative stress causing reduced glutathione depletion by 32% and increasing thiobarbituric acid reactive substances (TBARS), nitric oxide (NO) by 43% and 81%, respectively. Rotenone caused the appearance of apoptotic neurons with cytoplasmic vacoulations. On the other hand, tramadol -treated control rats showed increased DA (74%), 5-HT (23%), 5-HIAA (50%) contents and decreased serotonin turnover (18.0%) without causing oxidative stress. In rotenone-intoxicated rats, tramadol (10 or 20 mg/kg) increased brain dopamine and at 20 mg/kg increased 5-HT and 5-HIAA. The drug increased PON-1 activity, restored AChE activity and alleviated the changes in lipid peroxidation and reduced glutathione, increased tumour necrosis factor-alpha (TNF-α) without changing the histopathological changes caused by rotenone. Conclusion: These results indicate that short-term use of tramadol in an experimentally-induced PD has dual effects that should be carefully weighed. Tramadol decreased oxidative stress and restored normal DA content and AChE activity that can help in PD. However, the drug resulted in increased proinflammatory cytokine TNF-α and 5-HT level.


  • Open Access

    Sensory Metabolite Profiling in a Date Pit Based Coffee Substitute and in Response to Roasting as Analyzed via Mass Spectrometry Based Metabolomics

    by Mohamed A. Farag, Asmaa M. Otify, Aly M. El-Sayed, Camilia G. Michel, Shaimaa A. ElShebiney, Anja Ehrlich, Ludger A. Wessjohann

    Interest in developing coffee substitutes is on the rise, to minimizing its health side effects. In the Middle East, date palm (Phoenix dactylifera L.) pits are often used as a coffee substitute post roasting. In this study, commercially-roasted date pit products, along with unroasted and home-prepared roasted date pits, were subjected to analyses for their metabolite composition, and neuropharmacological evaluation in mice. Headspace SPME-GCMS and GCMS post silylation were employed for characterizing its volatile and non-volatile metabolite profile. For comparison to roasted coffee, coffee product was also included. There is evidence that some commercial date pit products appear to contain undeclared additives. SPME headspace analysis revealed the abundance of furans, pyrans, terpenoids and sulfur compounds in roasted date pits, whereas pyrroles and caffeine were absent. GCMS-post silylation employed for primary metabolite profiling revealed fatty acids’ enrichment in roasted pits versus sugars’ abundance in coffee. Biological investigations affirmed that date pit showed safer margin than coffee from its LD50, albeit it exhibits no CNS stimulant properties. This study provides the first insight into the roasting impact on the date pit through its metabolome and its neuropharmacological aspects to rationalize its use as a coffee substitute.


  • Open Access

    Novel polysaccharide hybrid scaffold loaded with hydroxyapatite: Fabrication, bioactivity, and in vivo study

    by Khairy M. Tohamy, Islam E. Soliman, Mostafa Mabrouk, Shaimaa ElShebiney, Hanan H. Beherei, Mohamed A. Aboelnasr, Diganta B. Das